Followers | 13 |
Posts | 1223 |
Boards Moderated | 0 |
Alias Born | 04/16/2024 |
Tuesday, July 30, 2024 5:21:33 PM
Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients
Agency feedback from Type C meeting process supports the company's proposed clinical development plans to expand the upliFT-D trial to assess PBFT02 in FTD patients with C9orf72 gene mutations
Recent PASG News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:41:45 PM
- Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference • GlobeNewswire Inc. • 09/23/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2024 11:00:19 AM
- Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT-D Study at 14th International Conference on Frontotemporal Dementias (ISFTD2024) • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Passage Bio Welcomes Tom Kassberg to Board of Directors • GlobeNewswire Inc. • 09/10/2024 11:52:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/10/2024 11:00:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2024 08:15:11 PM
- Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 08/30/2024 11:00:00 AM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/09/2024 09:15:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 11:15:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 11:00:22 AM
- Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights • GlobeNewswire Inc. • 08/08/2024 11:00:00 AM
- Passage Bio to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 08/06/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 08:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:00:47 AM
- Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration • GlobeNewswire Inc. • 08/01/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 11:01:19 AM
- Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 Patients • GlobeNewswire Inc. • 07/16/2024 11:00:00 AM
- Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference • GlobeNewswire Inc. • 06/05/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 08:52:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:03:29 PM
- Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award • GlobeNewswire Inc. • 05/21/2024 12:00:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/14/2024 12:15:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 11:15:50 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:01:06 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM